missing translation for 'onlineSavingsMsg'
Learn More
Learn More
ZEB1 Antibody (2A8H3) - BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody
Brand: Novus Biologicals NBP2-37329-0.025ml
This item is not returnable.
View return policy
Description
ZEB1 Monoclonal specifically detects ZEB1 in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, CyTOF-ready.
Specifications
| ZEB1 | |
| Monoclonal | |
| 1 mg/mL | |
| Western Blot 1:500 - 1:2000, Flow Cytometry 1:200 - 1:400, ELISA 1:10000, Immunohistochemistry 1:200 - 1:1000, Immunocytochemistry/Immunofluorescence 1:200 - 1:1000, Immunohistochemistry-Paraffin 1:200 - 1:1000, CyTOF-ready | |
| AREB6MGC133261, delta-crystallin enhancer binding factor 1, DELTAEF1, FECD6, Negative regulator of IL2, NIL2A, NIL-2-A, NIL-2-A zinc finger protein, posterior polymorphous corneal dystrophy 3, PPCD3, TCF-8, TCF8BZP, Transcription factor 8, transcription factor 8 (represses interleukin 2 expression), ZEB, Zfhep, ZFHX1A, zinc finger E-box binding homeobox 1, zinc finger E-box-binding homeobox 1, zinc finger homeodomain enhancer-binding protein | |
| Mouse | |
| 124 kDa | |
| 0.025 mL | |
| Cancer, Chromatin Research, Immunology, Neuroscience, Signal Transduction, Transcription Factors and Regulators, Vision, Zinc Finger | |
| 6935 | |
| Store at 4°C short term. Aliquot and store at-20°C long term. Avoid freeze/thaw cycles. |
| Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
| 2A8H3 | |
| Unconjugated | |
| PBS with 0.05% Sodium Azide | |
| ZEB1 | |
| Purified recombinant fragment of human ZEB1 (AA: 967-1108) expressed in E. Coli. | |
| Affinity Purified | |
| RUO | |
| Primary | |
| Human | |
| IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction